VXRT News and Press, Vaxart Inc. From 07/09/20

Vaxart (NASDAQ: VXRT) , a biotech company focused on the development of oral vaccines, had an underwhelming performance in the stock market in 2019 with its shares dropping by more than 80%. But largely thanks to the company's efforts to develop a vaccine for COVID-19, the stock has soared by...

Biotech Stocks Are On The Rise Amid News From Novavax When we hear the term coronavirus stocks , it can refer to a broad range of sectors. Depending on the context, it could be the new-economy stocks, spanning from gaming companies and online food delivery to biotech stocks . Like it or not,...

The race for a coronavirus vaccine is heating up. Operation Warp Speed is giving resources to small companies. Novavax (NVAX), Inovio (INO), Moderna (MRNA), Vaxart (VXRT), and VBI Vaccines (VBIV) are the current leaders. Currently, vaccine candidates for the coronavirus are in various stag...

July 8, 2020 Palm Beach, FL – July 8, 2020 – The entire global medical community has focused on finding treatments and vaccines to defeat the current global health crisis. Some treatments are showing signs of helping patients survive but a vaccine is the “Holy...

A COVID-19 vaccine will be worth billions and billions of dollars. It will likely be the most valuable drug on the planet. There are many pharmaceutical companies are pursuing a vaccine, and the market has already started rewarding some of them. Right now the big winners are small-cap biotech va...

Don’t Believe In Penny Stocks? This Might Make You Think Twice What comes to mind when you think about penny stocks ? Low price stock, B.S. companies, or maybe even long-shot lottery tickets? There’s no right or wrong answer to this question but there is an answer to the next qu...

A "black swan" event is a highly unusual, utterly unpredictable happening that throws everybody for a loop. As far as the stock market is concerned, black swans are almost always bad. For instance, 9/11 was a black swan. COVID-19 is a black swan, too.  The coronavirus, which did not exis...

Corvus Pharmaceuticals (NASDAQ: CRVS ) +103%  on launch immunotherapy study for COVID-19. More news on: Corvus Pharmaceuticals, Inc., Annovis Bio, Inc., Novavax, Inc., Stocks on the move, , Read more ...

Vaxart (VXRT) has soared over 2,000% YTD amid an acceptance to the Russell 3000, joining Operation Warp Speed, and the possibility of an effective COVID-19 'tablet' vaccine. The COVID-19 hype in other small-cap, speculative vaccine players like Novavax ( NVAX ), Inovio ( INO ), and Sorrento Th...

Introduction Vaxart ( VXRT ) is a small cap, clinical-stage biotech company based in South San Francisco, California that develops oral tablet vaccines to protect against infectious diseases caused by coronavirus, norovirus, seasonal influenza, respiratory syntactical virus (RSV), and...